Vertex announces data from a phase II study evaluating its NaV1.8 pain signal inhibitor, suzetrigine, for treating painful lumbosacral radiculopathy. Shares down.
For people with diabetes, peripheral neuropathy is the most common form ... You should always talk to your doctor before trying any new treatment. “Some patients explore [complementary therapies ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor in people with ...
Although the heart has its own nervous system, its organization and functionality remain largely unknown. Here, the authors reveal the molecular, chemical, and functional diversity of neurons ...
The Neuropathy Action Foundation (NAF), a non-profit organization dedicated to ensuring neuropathy patients have access to the treatments necessary to improve their quality of life, ...
As part of World Diabetes Day 2024, P&G Health, makers of Neurobion brought together renowned health experts from Philippines, Indonesia and Malaysia for deliberations on the latest research findings ...